At the 2019 ATS conference in Dallas, TX, USA, Frank Sciurba (University of Pittsburgh Medical Centre, Pittsburgh, PA, USA) discusses the challenges faced by patients with heterogeneous emphysema with negative collateral ventilation (CV) status and the potential of the Zephyr Valve to improve lung function, exercise tolerance and quality of life.
1. What challenges do patients with heterogeneous emphysema with negative collateral ventilation (CV) status currently face? (0:04)
2. Please briefly outline how the Zephyr Valve works in patients with heterogeneous emphysema with negative CV. (0:45)
3. What is the relationship between reductions in global hyperinflation and clinical outcomes such as lung function, exercise tolerance and quality of life, and how does the Zephyr Valve affect these? (1:43)
4. How long does it take for improvements with the Zephyr Valve? (2:45)
5. What unmet needs remain for patients with emphysema? (3:45)
Speaker’s Disclosures: Frank Sciurba has received institutional research funds from Pulmonx.
touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at ATS 2019, Dallas, TX, USA, May 2019.
Share this Video
Related Videos In Interventional Pulmonology
Daniel Steinfort, ERS 2022: A Novel Externally Cooled Bronchoscopic Radiofrequency Ablation Catheter for Ablation of Peripheral Lung Tumours
With lung cancer as the leading cause of cancer-related death worldwide and with the risk of complications from invasive surgeries, there is a need for minimally invasive ablative therapies for the treatment of lung tumours. It was a pleasure to talk with Dr. Daniel Steinfort (Royal Melbourne Hospital, Melbourne, Australia) to learn more around the […]
Frank Sciurba, ATS 2022: 2 Year Results from a Feasibility Study of Bronchial Rheoplasty for Chronic Bronchitis
We caught up with Prof. Frank Sciurba (University of Pittsburgh, Pittsburgh, PA, USA) to discuss the 2 year findings from a US feasibility study of bronchial rheoplasty for chronic bronchitis and to learn more around the upcoming advances in chronic bronchitis. The abstract ‘Bronchial Rheoplasty for Chronic Bronchitis: 2 Year Results from a Us Feasibility […]
Alan Kirk, ERS 2021: The TRANSFORM Study – A 24-month Follow-up
We were delighted to catch up with Mr Alan Kirk (Golden Jubilee National Hospital, West Dunbartonshire, Scotland, UK) to discuss the 24-month follow-up to the TRANSFORM study, investigating endobronchial valve treatment for patients with severe heterogeneous emphysema. The abstract ‘Durability of Zephyr Valve treatment: 24-month follow-up in the TRANSFORM Study.‘ (Presentation ID: 1201) was presented at […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!